ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior Manager/Associate Director, Marketing Operations at Cogent Biosciences - ApplyBlast

Senior Manager/Associate Director, Marketing Operations

Cogent Biosciences

6 months ago

3.8 on Glassdoor

Remote

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Senior Manager of Marketing Operations for Cogent Biosciences, responsible for managing the tactical execution of marketing operations supporting the launch of bezuclastinib, ensuring compliant, efficient, and impactful delivery of promotional content, omnichannel campaigns, and key marketing KPIs.

Responsibilities

Omnichannel Campaign Orchestration
Promotional Review & Content Approval
Agency & Vendor Management
Governance

Skills

Qualifications

Bachelor’s degree in Marketing, Business, Life Sciences, or related field; advanced degree preferred.4-5+ years of experience in pharmaceutical or biotech industry, with significant experience in oncology and/or rare diseases preferred.3+ years of developing, accelerating, and standardizing omnichannel operations processes aligned with the wider omnichannel vision.Proven leadership in promotional review, omnichannel execution, and vendor management.Deep understanding of regulatory requirements, including FDA, PAAB, and global compliance standards.

About Cogent Biosciences

cogentbio.com

Headquarters

Waltham, Massachusetts, United States

Company Size

51-200 employees

Founded

2014

View Profile

Cogent Biosciences is a biotechnology company focused on developing precision therapies for genetically defined diseases, including cancers, autoimmune conditions, and rare diseases. The company leverages validated biology to design best-in-class small molecule therapeutics, with its lead program bezuclastinib targeting conditions such as Systemic Mastocytosis and Gastrointestinal Stromal Tumors (GIST). Cogent operates discovery and development offices in Boulder, Colorado and Waltham, Massachusetts, and is actively advancing clinical-stage programs including a Phase 3 trial and an FDA-accepted NDA for bezuclastinib.